Insufficient scRNA-seq data for expression of PCDHA13 at single-cell level.
Insufficient scRNA-seq data for expression of PCDHA13 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 87% | 27.85 | 2294 / 2642 | 10% | 0.24 | 69 / 705 |
| pancreas | 90% | 16.48 | 294 / 328 | 1% | 0.01 | 2 / 178 |
| thymus | 82% | 11.57 | 538 / 653 | 4% | 0.05 | 24 / 605 |
| breast | 79% | 9.34 | 361 / 459 | 7% | 0.14 | 76 / 1118 |
| uterus | 78% | 10.78 | 133 / 170 | 1% | 0.02 | 5 / 459 |
| adipose | 77% | 9.35 | 924 / 1204 | 0% | 0 | 0 / 0 |
| lung | 70% | 9.08 | 404 / 578 | 4% | 0.08 | 48 / 1155 |
| adrenal gland | 55% | 4.88 | 141 / 258 | 17% | 0.49 | 39 / 230 |
| kidney | 60% | 5.12 | 53 / 89 | 3% | 0.05 | 24 / 901 |
| esophagus | 52% | 9.60 | 758 / 1445 | 5% | 0.10 | 9 / 183 |
| intestine | 52% | 4.00 | 501 / 966 | 2% | 0.04 | 8 / 527 |
| ovary | 49% | 3.51 | 89 / 180 | 1% | 0.01 | 3 / 430 |
| bladder | 43% | 3.24 | 9 / 21 | 1% | 0.02 | 6 / 504 |
| prostate | 29% | 1.86 | 71 / 245 | 9% | 0.20 | 47 / 502 |
| liver | 32% | 4.41 | 73 / 226 | 3% | 0.04 | 12 / 406 |
| stomach | 30% | 1.95 | 106 / 359 | 2% | 0.04 | 6 / 286 |
| spleen | 27% | 1.71 | 66 / 241 | 0% | 0 | 0 / 0 |
| skin | 17% | 1.01 | 307 / 1809 | 6% | 0.08 | 27 / 472 |
| blood vessel | 16% | 1.04 | 220 / 1335 | 0% | 0 | 0 / 0 |
| heart | 10% | 0.59 | 89 / 861 | 0% | 0 | 0 / 0 |
| muscle | 6% | 0.32 | 49 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 4% | 0.04 | 3 / 80 |
| peripheral blood | 2% | 0.12 | 19 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0007155 | Biological process | cell adhesion |
| GO_0007399 | Biological process | nervous system development |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005509 | Molecular function | calcium ion binding |
| Gene name | PCDHA13 |
| Protein name | Protocadherin alpha-13 (PCDH-alpha-13) Protocadherin alpha 13 |
| Synonyms | CNRS5 |
| Description | FUNCTION: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain. |
| Accessions | Q9Y5I0 ENST00000708327.1 [Q9Y5I0-2] ENST00000289272.3 [Q9Y5I0-1] ENST00000708325.1 [Q9Y5I0-1] C9JA99 ENST00000617769.1 [Q9Y5I0-2] ENST00000409494.5 |